-
Mashup Score: 8
In the United States (US), cancer is a leading cause of non-AIDS death among people living with HIV (PWH) [1]. Although cancer contributes significantly to morbidity and mortality among PWH, adults with HIV are less likely to receive curative cancer treatment compared to cancer patients without HIV with the same type and stage of cancer [2,3]. One important factor that impacts cancer treatment decisions is physician knowledge and perceptions. Oncologists may choose to withhold treatment from PWH with cancer due to a lack of information about appropriate treatment paradigms.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Emotional impact of cancer from a patient's perspective - 17 day(s) ago
Your work in geriatric oncology places you in a unique position to help people in the most significant way possible–to literally save their lives. Such a duty of care is profound, perhaps even more so when you face the most vulnerable patients– including children, the underprivileged, or those diminished by prior illness or the aging process itself.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet-
RT @JGeriOnc: Emotional impact of cancer from a patient's perspective https://t.co/gEknMeCFMU @WilliamDale_MD @rochgerionc @myCARG #GeriOnc…
-
-
Mashup Score: 15The effect of lifestyle interventions on sarcopenia in advanced colorectal cancer: A systematic review - 29 day(s) ago
Sarcopenia is a common syndrome in older patients with advanced colorectal cancer that is worsened during standard-of-care chemotherapy and is associated with increased chemotherapy toxicity, impaired quality of life, and poorer survival independent of cancer stage or chemotherapy response. Physical activity and nutrition interventions have been shown to support muscle mass in patients recovering from treatment for early-stage colorectal cancer. The aim of this present review was to evaluate the effect of physical activity and nutritional interventions on sarcopenia in patients with advanced colorectal cancer.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
The effect of lifestyle interventions on sarcopenia in advanced colorectal cancer: A systematic review https://t.co/9VblNFQNNB @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #Sarcopenia #ColorectalCancer #Lifestyle https://t.co/1QeWkisULb
-
-
Mashup Score: 28
The worldwide population is ageing, alongside an increase in cancer incidence rates. Over the past 10 years, there has been huge progress in the field of oncology with earlier diagnosis and an expansion of treatment options, leading to a growing number of older people living with cancer. That has meant that caring for older patients with cancer is now part of day-to-day oncology practices. This cohort often has geriatric syndromes and a higher prevalence of frailty and complex needs and preparing our clinical services to optimise care for these patients is essential.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
The care of older patients with cancer across the United Kingdom in 2024: A narrative review by the International Society of Geriatric Oncology UK Country Group https://t.co/eLzJp5xWAi @kwokleungcheung @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG https://t.co/6mOHlajCQW
-
-
Mashup Score: 39Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy - 1 month(s) ago
Chemotherapy toxicity tools are rarely studied in patients with hematologic malignancy (HM). The primary aim of this pilot study was to determine the predictive ability of the Cancer and Aging Research Group (CARG) chemo-toxicity calculator in estimating grade 3–5 toxicity in patients with HM.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy https://t.co/n3157eUlIQ @Ashley_Rosko1 @SarahAllison10 @KrokSchoen @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/GDk9ZeoSPY
-
-
Mashup Score: 11
Breast cancer is one of the most common malignancies diagnosed in older adults [1]. Older adults often will live several years with metastatic breast cancer and face age-related health concerns such as frailty and functional decline in addition to symptoms related to their cancer and treatments.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet-
RT @JGeriOnc: Geriatric assessment in older adults with metastatic breast cancer: A pilot study https://t.co/227HRnfEG2 @WilliamDale_MD @ro…
-
-
Mashup Score: 11
Breast cancer is one of the most common malignancies diagnosed in older adults [1]. Older adults often will live several years with metastatic breast cancer and face age-related health concerns such as frailty and functional decline in addition to symptoms related to their cancer and treatments.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet-
RT @JGeriOnc: Geriatric assessment in older adults with metastatic breast cancer: A pilot study https://t.co/227HRnfEG2 @WilliamDale_MD @ro…
-
-
Mashup Score: 37Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology - 2 month(s) ago
Corticosteroids are used frequently in oncology and many patients require short- or long-term corticosteroid therapy. General clinical guidelines and recommendations exist on the use of corticosteroids; however, evidence is lacking for recommendations on their appropriate use in older adult with cancer.Treatment of chemotherapy-induced nausea and vomiting (CINV) has dramatically improved over the last decade with 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists and neurokinin-1 (NK−1) receptor antagonists or a combination of both.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology https://t.co/lzYnAws3J4 @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG https://t.co/hyqY9PmXD1
-
-
Mashup Score: 12
Cancer management in older frail patients can be complex, given the high decline in functional status, comorbidity, and limited life expectancy affecting this group of patients. Therefore, this study aimed to investigate whether oncological treatment combined with comprehensive geriatric assessment (CGA) and tailored follow-up interventions improved or maintained quality of life (QoL) in older prefrail and frail patients with cancer.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet-
RCT specialized geriatric f/u (vs PCP f/u) in frail/prefrail solid tumor pts: - 363 pts, 58% frail, 55% M1 - no difference in any QOL or PROs between arms Important negative study; different interventions may be needed for specific malignancies. #gerionc https://t.co/A8GA5E1IhH
-
-
Mashup Score: 3Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer - 2 month(s) ago
Abiraterone and enzalutamide are treatments for metastatic castration-resistant prostate cancer (mCRPC). Due to a lack of head-to-head trials, they are prescribed interchangeably. However, the drugs have different pharmacokinetics and thus may have differing efficacy and adverse effects influenced by patient functional status and comorbid diseases. Additionally, mCRPC mainly affects older adults and since the prevalence of frailty increases with age, frailty is an important patient factor to consider in personalizing drug selection.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet-
@AaronGoodman33 Shameless plug, retrospective studies of old and frail patients should compare similar treatments, while not as good as randomized prospective, they may provide the best data available since some prospective trials are not feasible https://t.co/LXT4wG6Kwd
-
Potential drug-drug interactions between cancer therapies and active antiretroviral treatments among Medicare-enrolled patients with cancer and HIV https://t.co/6usErhKk4I @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/NvoFoXfgiF